Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Digital Engagement Phenotypes and 6-Month Weight Loss in a Tirzepatide-Supported Digital Weight-Loss Program: A Retrospective Cohort Study
Medicina (Kaunas, Lithuania), 2026;62(9)
GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap
Pharmaceutics, 2026;18(9)
Primary Colonic Mucosal-Associated Lymph Tissue Lymphoma: A Case Report
Case reports in gastroenterology, 2026;20(1):377-383
Estimating treatment effects in clinical studies of Alzheimer’s disease: What are estimands and why do we need them?
Alzheimer's & dementia : the journal of the Alzheimer's Association;22(8):e71676
Body Composition and Lifestyle Interventions in Pharmacological Treatment of Acquired Hypothalamic Obesity: A Systematic Review of Randomized Controlled Trials
Obesity (Silver Spring, Md.);34(9):1687-1698
IDE-mediated GLP-1 degradation as the basis for designing long-acting and CNS-stable GLP-1 receptor agonists
Science advances, 2026;12(35):eaeh4670
PharmaPlain: SOUL trial looking at the effect of oral semaglutide on cardiovascular outcomes in people with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease
European heart journal. Cardiovascular pharmacotherapy, 2026
Nonscarring Alopecia in Adults Treated With GLP-1s: A Propensity Score Matched TriNetX Cohort Study
The Laryngoscope, 2026
Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness
JAMA psychiatry, 2026
GLP-1 Receptor Agonists and Obesity Related Cancers: What We Know So Far
Current oncology reports, 2026;28(1)
Inappropriate use of GLP-1-based antiobesity medications: beyond appropriate drug use toward appropriate weight reduction
Diabetology international, 2026;17(4):71
Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception
Cardiovascular diabetology, 2026;25(1)
Association of semaglutide use with kidney outcomes in adults with ADPKD: A propensity score-matched real-world study
Science progress, 2026;109(3):368504261484176
Analytical methods for the determination of semaglutide in pharmaceutical formulations and biological matrices: A comprehensive review
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2026;1283:125267
Online-Sourced Retatrutide Complicating Impending Diabetic Ketoacidosis in a Patient With Type 1 Diabetes and Concurrent Shigella Gastroenteritis
Cureus, 2026;18(8):e115260
Social Media Discussions of Anti-Diabetic Drugs and the Popularity of GLP-1 Therapies: Content Analysis
JMIR diabetes, 2026;11:e87590
Digital Engagement and Predictors of Semaglutide Persistence and Weight Loss in Severe Obesity: 48-Week Observational Study
Journal of medical Internet research, 2026;28:e80119
Use of incretin receptor agonists in patients submitted to metabolic bariatric surgery – a systematic review and meta-analysis
Frontiers in endocrinology, 2026;17:1870008
Electroacupuncture enables semaglutide dose sparing in type 2 diabetes by boosting drug concentration and suppressing β-cell apoptosis
Frontiers in endocrinology, 2026;17:1880819
Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies
The American journal of managed care;32(7):392-395